Making sense of genetic heterogeneity
Emergence of pathways in developmental brain disorders
Citation Manager Formats
Make Comment
See Comments

Article Information
- First Published January 2, 2013.
Article Versions
- Previous version (January 2, 2013 - 12:56).
- You are viewing the most recent version of this article.
Author Disclosures
- Alex R. Paciorkowski, MD and
- Basil T. Darras, MD
- Alex R. Paciorkowski, MD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Basil T. Darras, MD
NONE
NONE
(1) Athena Diagnostics, Honorarium for Virtual Grand, Rounds (SMA) - 2010
NONE
NONE
(1) Various titles, UpToDate, 1999-present
NONE
(1) ISIS Pharmaceuticals, (2) Quest Diagnostics, (3) Guidepoint Global Consultation, (4) Easton Associates Consultation, (5) Gershon Lehrman Group
(1) Athena Diagnostics
NONE
NONE
(1) PTC Therapeutics, (2) Isis Pharmaceuticals
(1) NIH/NIAMS, 2P01 NS040828-6A11, co-PI, 2000-2012. (2) NIH/NINDS, 1U10NS077269, co-PI/PD, 2011-2018. (3) NIH/NIAMS, 1R01AR060850, co-PI, 2011-2015.
NONE
(1) SMA Foundation, (2) Muscular Dystrophy Association, (3) Slaney Family Fund for SMA
NONE
NONE
NONE
NONE
NONE
NONE
- From the Departments of Neurology, Pediatrics, and Biomedical Genetics (A.R.P.), Center for Neural Development & Disease, University of Rochester Medical Center, Rochester, NY; and Department of Neurology (B.T.D.), Boston Children's Hospital, Harvard Medical School, Boston, MA.
- Correspondence to Dr. Paciorkowski: alex_paciorkowski{at}urmc.rochester.edu
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.